Original Title:&nbsp;Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insight the Edwards SAPIENS Aortic Bioprosthesis Outcome (SOURCE) registry.&nbsp;Reference:&nbsp;Holger Eggerbrecht, et al. EuroIntervention 2014;10:975-81 SOURCE register data from patients receiving transcatheter aortic valve implantation with the Edwards Sapiens valve, were analyzed; out of 2307 patients, 27 (1.2%) required emergency cardiac surgery (ECS). Valve stenosis was<a href="https://solaci.org/en/2015/01/16/frequency-indication-and-evolution-of-emergency-cardiac-surgery-during-tavi/" title="Read more" >...</a>

Original title:&nbsp;Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease.&nbsp;Reference:&nbsp;Darren Mylotte, et al. J Am Coll Cardiol 2014;64:2330-9 The bicuspid aortic valve (BAV) is present between 0.5% and 2% of the general population and up to 20% of patients older than 80 years who require aortic valve surgery. Literature on &nbsp; &nbsp; transcatheter aortic valve<a href="https://solaci.org/en/2015/01/08/promising-results-of-tavr-in-bicuspid-aortic/" title="Read more" >...</a>

Echocardiography &nbsp;Favaloro Foundation. Buenos Aires, Argentina. JACC Cardiovascular Imaging has recently published a retrospective analysis including severe aortic stenosis patients (&lt; 1 cm&sup2;), with low gradient (mean aortic gradient Patients that had undergone dobutamine stress echocardiography (DSE) to distinguish pseudo aortic stenosis (n=49) were selected. These results were used to determine flow reserve (FR). The<a href="https://solaci.org/en/2014/12/18/stress-echocardiography-in-low-flow-low-gradient-aortic-stenosis-with-deteriorated-systolic-function/" title="Read more" >...</a>

Original title:&nbsp;Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French Aortic National CoreValve and Edwards 2 registry.&nbsp;Reference:&nbsp;Oguri A et al. CircCardiovascInterv. 2014; 7:602-610. &nbsp; Transcatheter aortic valve replacement (TAVI) performed under local anesthesia is becoming an increasingly common procedure. This study compared clinical outcomes in patients<a href="https://solaci.org/en/2014/11/12/transfemoral-tavi-under-local-anesthesia-with-similar-results-to-general-anesthesia/" title="Read more" >...</a>

Original title:&nbsp;Initial German Experience With Tranapical Implantation of a Second-Generation Trascatheter heart Valve for the Treatment of Aortic Regurgitation.&nbsp;Reference:&nbsp;Moritz Seiffert, et al. JACC Cardiovasc Interv. 2014 Oct;7(10):1168-74. There is a group of patients with severe aortic regurgitation and they are not candidates for surgery; percutaneous implant is an option, but until now, there is little<a href="https://solaci.org/en/2014/11/11/tavi-also-a-promising-option-for-severe-aortic-regurgitation/" title="Read more" >...</a>

Original title:&nbsp;Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation.&nbsp;Reference:&nbsp;Freixa X et al. Catheter Cardiovasc Interv. 2014;Epub ahead of print. This single center study analyzed data form 56 consecutive patients with severe aortic stenosis and LVEF of &le; 50% undergoing TAVI (transcatheter aortic valve implantation) between March 2006<a href="https://solaci.org/en/2014/10/06/worse-post-tavi-ejection-fraction-recovery-in-coronary-artery-disease-patients-without-revascularization/" title="Read more" >...</a>

Original title:&nbsp;Percutaneous Mitral Valve Repair for Mitral Regurgitation in High-Risk Patients. Results of the EVEREST II Study.&nbsp;Reference:&nbsp;Donald D. Glower et al. J Am Coll Cardiol 2014;64:172-81 Severe mitral regurgitation (MR) often lead to hospitalization for cardiac failure and heart surgery. Half of these patients are rejected for high surgical risk. Percutaneous intervention is a valid<a href="https://solaci.org/en/2014/09/24/mitra-clip-a-valid-alternative-for-high-risk-patients/" title="Read more" >...</a>

Original title:&nbsp;Comparison of Transfemoral TranscatheterAortic Valve Replacement Performedin the Catheterization Laboratory(Minimalist Approach) Versus HybridOperating Room (Standard Approach). Outcomes and CostAnalysis.&nbsp;Reference:&nbsp;VasilisBabaliaros et al. J Am CollCardiolIntv 2014;7:898&ndash;904. This retrospective study of a center analyzed the results of percutaneous aortic valve replacement (TAVR) performed with a minimally invasive technique that included the closure of the femoral access<a href="https://solaci.org/en/2014/08/25/tavr-minimally-invasive-shorter-hospital-stay-and-costs-without-compromising-safety-or-efficacy/" title="Read more" >...</a>

Original title:&nbsp;Early Regression of Severe Left Ventricular Hypertrophy After Transcatheter Aortic Valve Replacement Is Associated with Decreased Hospitalization.&nbsp;Reference:&nbsp;Brian Lindman, et al. JACC Cardiovasc Interv 2014;7:662-73. &nbsp; Left ventricular hypertrophy, defined by the increase of left ventricular mass, has long been associated to increased morbi-mortality in the context of different heart conditions. LV hypertrophy regression might<a href="https://solaci.org/en/2014/08/05/tavr-regression-of-left-ventricular-hypertrophy-decreases-re-hospitalization/" title="Read more" >...</a>